Laboratory Testing & Advisory Services
•98 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (98)
%
| Company | Market Cap | Price |
|---|---|---|
|
Thermo Fisher offers Laboratory Testing & Advisory Services (outsourced testing and regulatory support).
|
$198.11B |
$524.80
-1.88%
|
|
Laboratory Testing & Advisory Services aligns with outsourced testing/advisory capabilities connected to diagnostics workflows.
|
$144.89B |
$202.46
-1.20%
|
|
Zoetis has elements of laboratory testing & advisory services related to diagnostics and biotherapeutics.
|
$62.82B |
$141.11
-1.59%
|
|
CrossLab includes laboratory testing and advisory services as well as service contracts and support.
|
$40.00B |
$140.11
-0.12%
|
|
MTD provides laboratory testing support and advisory services (e.g., calibration-related services) as a service offering.
|
$26.47B |
$1273.67
-2.72%
|
|
BWXT's strategy includes Laboratory Testing & Advisory Services via Kinectrics integration for testing and regulatory support.
|
$17.37B |
$190.08
-2.82%
|
|
Primary business includes Laboratory Testing & Advisory Services, including genomics and hereditary testing via Ambry Genetics.
|
$16.69B |
$96.39
-4.47%
|
|
The company provides data services and advisory support around sequencing workflows and results interpretation.
|
$14.86B |
$93.86
-2.73%
|
|
Directly provides Laboratory Testing & Advisory Services (TIC) and related testing/advisory work.
|
$14.47B |
$72.16
-1.57%
|
|
Medpace offers bio-analytical laboratory services and regulatory advisory as part of its CRO offerings.
|
$14.41B |
$501.22
-3.28%
|
|
The company offers Laboratory Testing & Advisory Services, including PFAS testing validated with regulatory agencies, aligning with PFAS remediation and environmental testing capabilities.
|
$12.53B |
$233.95
+0.58%
|
|
Owns/operates lab testing facility Trybe Labs enabling diagnostics and data for treatment customization.
|
$12.08B |
$53.95
-7.45%
|
|
Laboratory testing and regulatory advisory services offered directly to customers.
|
$9.91B |
$84.06
+0.79%
|
|
Renal labs and testing integrated into kidney care services.
|
$9.36B |
$123.99
-2.28%
|
|
Bio-Techne provides laboratory testing and advisory services, including outsourcing and regulatory guidance for labs.
|
$8.72B |
$55.63
+6.51%
|
|
Laboratory testing and advisory services are provided to customers and pharma partners.
|
$7.96B |
$64.22
-3.53%
|
|
Laboratory testing and advisory services support utilities and renewables, reflecting ESCO's testing/analytics capability in USG.
|
$5.45B |
$210.07
-0.42%
|
|
Nelson Labs provides outsourced laboratory testing and advisory services, a core service line.
|
$4.36B |
$15.35
-2.66%
|
|
Laboratory Testing & Advisory Services: provision of genetic diagnostic tests and related advisory services.
|
$3.47B |
$121.72
-4.53%
|
|
Veracyte provides laboratory testing services and advisory/clinical-evidence support for test development and deployment.
|
$2.73B |
$34.80
-0.66%
|
|
Laboratory Testing & Advisory Services: includes bench-scale refining/testing activities tied to processing trials (via partners).
|
$2.68B |
$7.41
+2.21%
|
|
Provides diagnostic testing and advisory services within its occupational health centers and onsite clinics.
|
$2.67B |
$20.82
+0.77%
|
|
GRAIL directly provides Laboratory Testing & Advisory Services through Galleri testing and associated clinical program activities.
|
$2.38B |
$66.13
-7.38%
|
|
Laboratory testing services and advisory capacity related to MRD diagnostics and sequencing.
|
$2.03B |
$13.36
-3.68%
|
|
Hospitals perform laboratory testing and offer advisory services as part of integrated patient care.
|
$2.01B |
$14.05
-2.57%
|
|
QuidelOrtho offers laboratory testing outsourcing and advisory services alongside its core testing offerings.
|
$1.78B |
$26.37
-6.56%
|
|
Laboratory testing & advisory services related to testing facilities and regulatory compliance.
|
$1.72B |
$45.83
-5.10%
|
|
Directly provides Laboratory Testing & Advisory Services, including testing, regulatory advisory, and related analytical capabilities.
|
$1.68B |
$13.75
-1.08%
|
|
Azenta offers laboratory testing and advisory services through its GENEWIZ Genomics Services platform, including sequencing and related data generation.
|
$1.41B |
$30.73
-3.30%
|
|
Laboratory Testing & Advisory Services aligns with Evotec's preclinical/testing and regulatory/compliance support offerings.
|
$1.38B |
$7.28
|
|
Neogen offers laboratory testing capabilities and advisory services around microbiology/genomics, aligning with outsourced testing and regulatory guidance.
|
$1.31B |
$6.04
-12.21%
|
|
OPKO's BioReference Diagnostics segment provides Laboratory Testing & Advisory Services (clinical/diagnostic testing).
|
$1.20B |
$1.51
-3.21%
|
|
Offers laboratory testing and advisory analytical services to customers.
|
$1.15B |
$25.53
-7.97%
|
|
Montrose provides laboratory testing and advisory services, including PFAS testing and regulatory advisory.
|
$948.82M |
$27.54
-0.69%
|
|
BST includes diagnostic/analytical kit products and related testing/advisory services for biologics manufacturing.
|
$812.36M |
$3.19
-3.92%
|
|
Datapoints and related data/analytical services align with Laboratory Testing & Advisory Services.
|
$791.35M |
$13.52
-12.04%
|
|
Laboratory testing and advisory services related to GLP capacity and regulatory support.
|
$730.80M |
$26.11
-10.61%
|
|
Laboratory Testing & Advisory Services: PSNL provides clinical laboratory testing and advisory services.
|
$717.20M |
$8.12
-6.67%
|
|
Laboratory testing and advisory services directly provided by the company, core to its business model.
|
$709.77M |
$7.72
+0.78%
|
|
Direct Laboratory Testing & Advisory Services across Precision Diagnostics, Anatomic Pathology, and BioPharma Services.
|
$685.29M |
$22.51
-1.01%
|
|
PIL-BOX space biotech work implies related Laboratory Testing & Advisory Services and analytical capabilities.
|
$673.71M |
$8.74
-8.19%
|
|
Castle Biosciences primarily delivers molecular diagnostic tests and laboratory testing services (DecisionDx-Melanoma, DecisionDx-SCC, TissueCypher, etc.), i.e., laboratory testing & advisory services.
|
$666.37M |
$23.08
-3.11%
|
|
LAB provides SomaScan services to customers (translational/clinical research), i.e., laboratory testing and advisory services.
|
$497.57M |
$1.31
-5.07%
|
|
Core Lab directly provides Laboratory Testing & Advisory Services for reservoir description and production optimization.
|
$484.30M |
$10.33
-4.35%
|
|
Operates Laboratory Testing & Advisory Services as part of its hospital/clinic network.
|
$484.16M |
$6.55
-0.30%
|
|
CTS-related advisory/testing services align with outsourced testing/advisory offerings.
|
$470.80M |
$18.24
-2.25%
|
|
Mesa provides laboratory testing services and regulatory/compliance advisory support as part of its offerings, fitting Laboratory Testing & Advisory Services.
|
$385.97M |
$70.75
+3.12%
|
|
MG provides laboratory testing & advisory services as part of asset integrity programs.
|
$312.04M |
$9.96
-2.54%
|
|
Laboratory testing and advisory services offered through LifeMD platform.
|
$280.41M |
$6.17
-5.95%
|
|
Exagen directly provides autoimmune diagnostic laboratory testing and advisory services via its AVISE CTD platform and related biomarker assays.
|
$197.13M |
$10.95
-0.64%
|
|
RCMT provides advisory and regulatory-support services via its Life Sciences & IT offerings, aligning with Laboratory Testing & Advisory Services.
|
$170.79M |
$23.11
-3.10%
|
|
Provides laboratory testing services and advisory/regulatory support tied to its diagnostics offerings.
|
$169.77M |
$13.89
-3.94%
|
|
Acquisition adds gene editing assessment services and lab testing/advisory offerings.
|
$167.98M |
$1.66
+5.06%
|
|
The company provides laboratory testing and advisory services related to MQC and validation activities.
|
$167.56M |
$3.79
+7.37%
|
|
Mobile phlebotomy and on-site laboratory testing services provided to patients.
|
$125.86M |
$1.27
-1.55%
|
|
EsoGuard is a laboratory DNA methylation test offered as a diagnostic service; falls under Laboratory Testing & Advisory Services.
|
$124.42M |
$1.15
-6.50%
|
|
SERA provides laboratory testing services for PreTRM and related advisory content.
|
$116.41M |
$2.95
-4.22%
|
|
Potential involvement in outsourced laboratory testing and advisory services related to its assays.
|
$111.25M |
$3.89
+2.37%
|
|
Tracer diagnostics studies and related data interpretation/ advisory services are offered as a service line.
|
$106.18M |
$41.79
-4.41%
|
|
Laboratory testing & advisory services associated with translational oncology and preclinical work.
|
$90.10M |
$6.54
-0.46%
|
|
Central Laboratory and testing services imply Laboratory Testing & Advisory Services (outsourced testing and regulatory support).
|
$86.30M |
$8.36
-4.46%
|
|
Laboratory Testing & Advisory Services aligns with WFCF’s auditing, verification, and compliance support.
|
$71.10M |
$13.64
+1.79%
|
|
Laboratory testing and advisory services including testing and regulatory compliance support related to inspection and heat-treating activities.
|
$66.64M |
$14.83
-1.72%
|
|
ABS lab services provide translational/clinical study support, acting as Laboratory Testing & Advisory Services.
|
$64.26M |
$1.29
|
|
Provides diagnostic testing and companion diagnostics services related to patient selection (OncoSignature).
|
$59.89M |
$1.91
+1.60%
|
|
Development Services is described as providing diagnostic testing services and regulatory/advisory support.
|
$53.64M |
$7.32
-6.75%
|
|
Nu.Q Discover generates revenue via laboratory testing & advisory services for pharma/biotech customers.
|
$47.81M |
$0.46
-10.75%
|
|
The company offers outsourced laboratory testing plus advisory and regulatory compliance support as part of its services.
|
$47.75M |
$1.39
-6.08%
|
|
The company’s processing and storage activities imply access to laboratory testing/advisory services in supporting cord blood banking operations.
|
$35.77M |
$4.43
+0.35%
|
|
Offers laboratory testing and advisory services around biomarkers and clinical testing.
|
$35.75M |
$2.02
|
|
Pathology Services / Laboratory testing is a core, directly-provided service offering.
|
$28.79M |
$19.04
-7.65%
|
|
CNSide Diagnostics offers laboratory testing services (LDTs) for CSF-based tumor enumeration and biomarkers.
|
$24.42M |
$0.72
-7.07%
|
|
The company provides laboratory services related to DRP algorithms and testing.
|
$24.28M |
$1.61
-8.52%
|
|
ProPhase Labs directly provides Laboratory Testing & Advisory Services via BE-Smart diagnostic testing.
|
$21.85M |
$0.53
+1.29%
|
|
Offers Laboratory Testing & Advisory Services related to regulatory compliance and GLP data for decontamination validation.
|
$20.22M |
$1.01
+1.01%
|
|
KTL mentions wet lab support and prototyping capabilities, aligning with laboratory testing and advisory services.
|
$16.05M |
$2.14
+3.88%
|
|
Includes regulatory advisory and compliance support services, aligning with Laboratory Testing & Advisory Services as a service category.
|
$13.82M |
$0.60
|
|
The company discusses regulatory strategies and potential lab testing/advisory services related to its diagnostic platform development.
|
$12.92M |
$0.38
+3.59%
|
|
MDxHealth provides Laboratory Testing & Advisory Services through its diagnostic tests and related operations.
|
$11.13M |
$4.08
-7.06%
|
|
MRNA Scientific provides outsourced laboratory testing and advisory services.
|
$9.32M |
$5.19
-3.71%
|
|
DiamiR/Aptorum's combined diagnostics and biomarker panels imply Laboratory Testing & Advisory Services for biopharma customers.
|
$9.08M |
$1.66
-30.83%
|
|
EsoGuard is a laboratory test/service delivered to clinicians, qualifying as Laboratory Testing & Advisory Services.
|
$8.61M |
$0.49
-13.83%
|
|
Laboratory testing and advisory services through CLIA-certified wet-lab operations supporting drug discovery.
|
$8.53M |
$14.32
+1.31%
|
|
Immco lab-based diagnostic testing and advisory services (lab testing, HIV screening, preeclampsia, etc.).
|
$8.05M |
$1.05
-3.67%
|
|
CDIO directly provides Laboratory Testing & Advisory Services through its in-house lab operations for epigenetic/genetic cardiovascular tests (EpiGen CHD, PrecisionCHD, ACI insights).
|
$7.22M |
$4.15
-7.37%
|
|
Boost Diagnostics and Pala Diagnostics provide diagnostic testing services, fitting Laboratory Testing & Advisory Services.
|
$6.85M |
$0.06
+23.91%
|
|
The narrative describes ongoing laboratory testing activities and regulatory/advisory services critical to bringing diagnostics to market.
|
$6.79M |
$0.04
|
|
Lineagen provides diagnostic testing and advisory services related to genomics, which are delivered directly to customers.
|
$6.76M |
$2.01
-1.95%
|
|
DNA examination lab and QC testing capability aligns with Laboratory Testing & Advisory Services.
|
$5.77M |
$1.48
-1.47%
|
|
XWEL's XpresTest segment provides laboratory testing and advisory services for bio-surveillance, including a multi-year CDC/Ginkgo Bioworks partnership and revenue from contracted testing programs.
|
$5.19M |
$0.99
-1.27%
|
|
Laboratory testing and advisory services delivering genomic testing and interpretation.
|
$3.94M |
$0.90
+5.28%
|
|
Industrial laboratory testing and advisory services are mentioned in the R&D/validation context and could be offered around the remediation technology.
|
$3.40M |
$0.17
-3.42%
|
|
Cannabis A3AR assay will be offered as fee-for-service laboratory testing and advisory services.
|
$2.66M |
$0.53
-7.02%
|
|
Provides Laboratory Testing & Advisory Services including cell testing and regulatory/compliance guidance.
|
$2.32M |
$0.01
|
|
CyPath Lung testing is delivered through a CLIA-certified commercial laboratory, constituting Laboratory Testing & Advisory Services.
|
$2.23M |
$2.45
-3.16%
|
|
PMGC Research may provide laboratory testing and advisory services (regulatory/analytical support).
|
$2.10M |
$5.31
-0.56%
|
|
Shuttle Diagnostics appears to encompass diagnostic testing/advisory services related to cancer diagnostics.
|
$1.67M |
$3.80
+6.74%
|
|
Functional and genetic testing mentioned as part of the clinic services, aligning with laboratory testing activities and advisory support.
|
$428457 |
$0.01
|
Loading industry metrics...
Loading comparison data...
